## MNDY: monday.com Ltd. - XLK: Technology

### Executive Summary

VALUE thesis: PEG 0.48 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($136.18)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 2
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Monday.com (MNDY) Falls on Disappointing Guidance and Smaller-Than-Expected Earnings Beat**
- Source: Yahoo Finance | 20251202T060920 | Somewhat-Bearish | Relevance: 100%
- Monday.com (MNDY) experienced a stock price fall due to disappointing guidance and an earnings beat that was smaller than anticipated. Despite Morgan Stanley lowering its price target while maintaining an Overweight rating, the firm remains confident in the company's long-term investment case, citing its focus on multi-product solutions and revenue generation from larger customers. Monday.com reported a 26% year-over-year revenue increase in Q3 2025, reaching $317 million, and projects continued growth for Q4 and the full year.

**2. Do You Have Long-Term Conviction in monday.com (MNDY)?**
- Source: Insider Monkey | 20251201T080900 | Somewhat-Bullish | Relevance: 100%
- Sands Capital Technology Innovators Fund maintains long-term conviction in Monday.com Ltd. (MNDY) despite recent share price declines due to conservative guidance and AI disruption fears. They believe the impact of these issues is short-term, citing MNDY's strong user base, product innovation, and improving sales execution. While the stock has seen significant losses recently, Sands Capital views it as an attractive risk-reward opportunity.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 0, Lowers: 12)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-11 | UBS | $200 | $215 | -7% |
| 2025-11-11 | Citigroup | $319 | $332 | -4% |
| 2025-11-11 | Jefferies | $300 | $330 | -9% |
| 2025-11-11 | Canaccord Genui | $230 | $255 | -10% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-11 | UBS | main | Neutral |
| 2025-11-11 | Citigroup | main | Buy |
| 2025-11-11 | Jefferies | main | Buy |
| 2025-11-11 | Canaccord Genui | main | Buy |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 38.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- WCM Investment Manag: 8.1% (+2.8%)
- JPMORGAN CHASE & CO: 5.8% (+63.1%)
- Sonnipe Ltd: 4.0% (-5.3%)
- Blackrock Inc.: 3.7% (+0.5%)
- FMR, LLC: 3.5% (-64.1%)

### Key Risks

1. Elevated short interest (8.1%): bears positioning against stock.
2. Long-term trend broken: trading 36.1% below SMA200.
3. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.48 indicates undervaluation relative to growth. Forward P/E 31.1x stretched relative to 15% growth. Balance sheet: strong liquidity (2.7x). Revenue growth strong at 22% YoY. Analyst sentiment negative (12 target cuts vs 0 raises). Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $7.5B |
| Beta | 1.26 |
| 52W Range | $141.20 - $342.64 |
| Short Interest | 8.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.48 |
| Forward P/E | 31.1 |
| Current P/E | 35.7 |
| YoY Growth | 14.9% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from -14.1% to -5.0% (+9.1% in 5 days), confirming momentum buildup. Below STRENGTH zone by 9.0pp (needs >4.0% for momentum thesis). MRS_5 turning positive (2.6%) - potential reversal signal. AM_20 at -3.2% indicates price below own 20MA trend. Underperforming sector by 4.6pp, stock-specific weakness. Below SMA200 (0.64x), long-term trend not supportive. MACD histogram positive (0.70), confirming momentum. RSI neutral at 40. OFD pattern: +MUL (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -4.99% (CS: 10) | Weak |
| RSI_14 | 40.4 | Neutral |
| MACD Histogram | 0.70 | Bullish |
| vs SMA20 | 0.968x | Below |
| vs SMA50 | 0.855x | Below |
| vs SMA200 | 0.639x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $152.52
- **Stop Loss:** $136.18 (10.7% risk)
- **Target:** $185.20 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 58
- **Position Value:** $8,846.16
- **Portfolio %:** 8.85%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-02-09 (Est: $0.91)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.88 | $1.16 | +32.5% |
| 2025Q2 | $0.86 | $1.09 | +27.0% |
| 2025Q1 | $0.70 | $1.10 | +56.4% |
| 2024Q4 | $0.79 | $1.08 | +36.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*